4-Methyl-2,5-methoxyphenylcyclopropylamine

From Infogalactic: the planetary knowledge core
(Redirected from DMCPA)
Jump to: navigation, search
4-Methyl-2,5-methoxyphenylcyclopropylamine
DMCPA.png
DMCPA-3d-sticks.png
Names
IUPAC name
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropanamine
Identifiers
69854-49-5 N
ChEMBL ChEMBL13530 YesY
ChemSpider 2285590 YesY
Jmol 3D model Interactive image
PubChem 3017965
  • InChI=1S/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3 YesY
    Key: HYVPPECPQRBJEQ-UHFFFAOYSA-N YesY
  • InChI=1/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3
    Key: HYVPPECPQRBJEQ-UHFFFAOYAN
  • O(c1c(cc(OC)c(c1)C2CC2N)C)C
Properties
C12H17NO2
Molar mass 207.27 g/mol
Vapor pressure {{{value}}}
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

DMCPA, or 4-methyl-2,5-methoxyphenylcyclopropylamine, is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 15–20 mg, and the duration is listed as 4–8 hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.

Pharmacology

Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.

See also

External links


<templatestyles src="Asbox/styles.css"></templatestyles>